Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis

Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis: a Single-center Prospective Observational Study

Complementary and alternative medicine are increasingly used all around the world and more specifically in chronic diseases such as atopic dermatitis. Sociodemographic and disease determinants associated with their use remain unclear. Moreover, most of studies involved children and little data are available for adults.

The main objective of this study is to identify factors associated with complementary and alternative medicine use in children and adults suffering from atopic dermatitis. The secondary objectives are to determine the prevalence of complementary and alternative medicine use, the main forms used and their modalities of use, patients' motivations for using these therapies and sources of information.

Patients of all ages consulting for their atopic dermatitis at the dermatology or pediatric allergology department of Nancy University Hospital over a 6 months period will be asked to fill out a questionnaire about their pathology and their use of complementary and alternative medicine. This questionnaire will be collected before they leave the hospital.

Study Overview

• Status: Completed
• Conditions: Atopic Dermatitis
• Intervention / Treatment: Behavioral: Self-administered questionnaire

• Study Type: Observational
• Enrollment (Actual): 89

Contacts and Locations

• Study Contact: Name: Anne-Claire Bursztejn; Phone Number: +33383157146; Email: ac.bursztejn@chru-nancy.fr

Study Locations

• France
  • Nancy, France
    • University Hospital Of Nancy
    • Contact: Anne-Claire Bursztejn; Phone Number: +33383157146; Email: ac.bursztejn@chru-nancy.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: N/A

• Sampling Method: Probability Sample

Study Population

Patients of all ages suffering from atopic dermatitis visiting the dermatology or pediatric allergology department of Nancy University Hospital

Description

Inclusion Criteria:

• All patients, adults or children, without age limit;
• Patients visiting the dermatology or pediatric allergology department of Nancy University Hospital;
• Patients with atopic dermatitis confirmed on clinical examination by the physician;
• Patients with a history of atopic dermatitis or newly diagnosed patients;
• Patient affiliated to a social security plan or beneficiary of such a plan;
• Patients who understand French and are able to complete a self-administered questionnaire or have the option of assistance in completing it.

Exclusion Criteria:

• Patient with at least one other dermatological pathology or non-atopic eczema (contact eczema, ...);
• Patient without a confirmed diagnosis of atopic dermatitis by a physician;
• Patient who has already completed the questionnaire during a previous consultation;
• Pregnant and breastfeeding women;
• Refusal of the patient or at least one of the parents for children;
• Patient placed under court protection, guardianship or curatorship;
• Patient deprived of liberty by a judicial or administrative decision.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Atopic dermatitis patients	Behavioral: Self-administered questionnaire; Self-administered questionnaire regarding complementary and alternative medicine use

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Binary variable: use of complementary and alternative medicine (yes/no)	Binary variable: use of complementary and alternative medicine (yes/no), variable collected by questionnaire, as reported by the patient (or the patient's parents)	Baseline (J0)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Percentage of patients using complementary and alternative medicine in relation to the total number of patients included in the study	Percentage of patients using complementary and alternative medicine in relation to the total number of patients included in the study, variable collected by questionnaire according to the patient's declaration (use or not use of complementary and alternative medicine) and then calculated	Baseline (J0)
Forms of complementary and alternative medicine used	Forms of complementary and alternative medicine used, variable collected by questionnaire, as reported by the patient (or the patient's parents)	Baseline (J0)
Modalities of use of complementary and alternative medicine	Modalities of use of complementary and alternative medicine, variable collected by questionnaire, as reported by the patient (or the patient's parents)	Baseline (J0)
Patients' motivations for using complementary and alternative medicine	Patients' motivations for using complementary and alternative medicine, variable collected by questionnaire, as reported by the patient (or the patient's parents)	Baseline (J0)
Sources of information regarding complementary and alternative medicine	Sources of information regarding complementary and alternative medicine, variable collected by questionnaire, as reported by the patient (or the patient's parents)	Baseline (J0)

Collaborators and Investigators

• Sponsor: Central Hospital, Nancy, France
• Investigators: Principal Investigator: Anne-Claire Bursztejn, University Hospital of Nancy, France

Study record dates

Study Major Dates

• Study Start (Actual): May 10, 2023
• Primary Completion (Actual): August 3, 2023
• Study Completion (Actual): August 3, 2023

Study Registration Dates

• First Submitted: April 2, 2023
• First Submitted That Met QC Criteria: April 18, 2023
• First Posted (Actual): April 27, 2023

Study Record Updates

• Last Update Posted (Actual): December 1, 2023
• Last Update Submitted That Met QC Criteria: November 28, 2023
• Last Verified: November 1, 2023

More Information

Terms related to this study

• Keywords: Atopic Dermatitis; Complementary and Alternative Medicine; Atopic Eczema
• Additional Relevant MeSH Terms: Skin Diseases; Immune System Diseases; Hypersensitivity, Immediate; Genetic Diseases, Inborn; Skin Diseases, Genetic; Hypersensitivity; Skin Diseases, Eczematous; Dermatitis; Eczema; Dermatitis, Atopic
• Other Study ID Numbers: 2023-A00605-40

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No